ShareValue scores for 300026.SHE: Valuation 77, Quality 42, Growth 31, Health 50.

300026.SHE
SZSE

Tianjin Chase Sun Pharmaceutical Co Ltd

CN¥3.41(+1.79%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

13% to 28%
Valuation
77
Undervalued
Price vs Value
Quality
42
Moderate
Business Strength
Growth
31
Weak
Revenue & Earnings
Health
50
Moderate
Financial Stability
Momentum
39
Bearish
Price Trend

Company Details

About

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and sale of various pharmaceutical products in China. The company offers traditional Chinese medicine formula granules; finished drugs, including xuebijing injections, low molecular weight heparin calcium injections, moxifloxacin hydrochloride sodium chloride injections, enoxaparin sodium injections, nadronexacin calcium injections, fasudil hydrochloride injections, ketorheic acid tromethamine injections, ibanoxetine sodium injections, Qingfei Sanjie pills, and Ping Wan anti-cancer pills; raw materials and excipients, such as pharmaceutical excipients, active pharmaceutical ingredients (APIs), and food additives; medical devices, including oxygen concentrators and portable oxygen concentrators; medical and health services; and intelligent supply chain services for pharmaceuticals and medical devices. It also provides chemical reagents, Western patent medicines, enteric casings, heparin sodium, food, beverages, seasonings, tea, candies, and traditional Chinese medicine decoction pieces; pharmaceutical equipment and self-owned housing leasing; pharmaceutical product and medical device research and development; technology consulting, transfer, and promotion; health management, business management, nutritional health, and health information consulting; wholesale and retail of electronic products; import and export of goods and technology; biopharmaceutical project management; project investment; technical service development, transfer, and consulting; consumer electronics and sporting goods sales; computer software and hardware development; general hospital services; nursing services for the elderly and disabled; medical management; diagnosis and treatment; and medical data research activities. The company exports its products to approximately 50 countries and regions. Tianjin Chase Sun Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Tianjin, China. Address: Building B01, Entrepreneurship Headquarters Base, Tianjin, China, 301700

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026